lunes, 22 de junio de 2026

Results From a Phase 3 Study of Voxzogo (Vosoritide) in Children With Hypochondroplasia by Madaline Spencer| Published on: Jun 22, 2026

Results From a Phase 3 Study of Voxzogo (Vosoritide) in Children With Hypochondroplasia by Madaline Spencer| Published on: Jun 22, 2026 Andrew Dauber, MD, Chief of Endocrinology at Children’s National Hospital, discusses results from a phase 3 study of Voxzogo (vosoritide) in children with hypochondroplasia. https://checkrare.com/results-from-a-phase-3-study-of-voxzogo-vosoritide-in-children-with-hypochondroplasia/

No hay comentarios:

Publicar un comentario